S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
TSLA   256.90 (-1.94%)
T   38.23 (+1.08%)
ACB   3.71 (-4.63%)
NFLX   275.30 (-6.15%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
TSLA   256.90 (-1.94%)
T   38.23 (+1.08%)
ACB   3.71 (-4.63%)
NFLX   275.30 (-6.15%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
Log in

Emmaus Life Sciences Price Target & Analyst Ratings (NASDAQ:EMMA)

$2.80
+0.32 (+12.90 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$2.40
Now: $2.80
$2.80
50-Day Range
$1.34
MA: $2.91
$4.25
52-Week Range
$1.33
Now: $2.80
$12.90
Volume34,698 shs
Average Volume56,586 shs
Market Capitalization$132.91 million
P/E RatioN/A
Dividend YieldN/A
Beta2.91

Analyst Ratings

Emmaus Life Sciences (NASDAQ:EMMA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Emmaus Life Sciences in the last 12 months. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldN/AN/AN/A
Consensus Rating Score: 2.00N/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Emmaus Life Sciences (NASDAQ:EMMA) Consensus Price Target History

Emmaus Life Sciences (NASDAQ:EMMA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/24/2019Dawson JamesDowngradeBuy ➝ NeutralHigh
(Data available from 10/18/2017 forward)
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel